The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Lau, G. K. K., Piratvisuth, T., Luo, K. X., Marcellin, P., Thongsawat, S., Cooksley, G., Gane, E., Fried, M. W., Chow, W. C., Paik, S. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043470 · Cited by 1,519
EASL clinical practice guidelines management of chronic hepatitis B
张学武, & Li, X. (2009) · Inter J Epidemiol Infect Dis · doi:10.3760/cma.j.issn.1673-4149.2009.04.001 · Cited by 1,506
Seeger, C., & Mason, W. S. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.1.51-68.2000 · Cited by 1,451
A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
Chang, T.-T., Gish, R. G., de Man, R., Gadano, A., Sollano, J., Chao, Y.-C., Lok, A. S., Han, K.-H., Goodman, Z., Zhu, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051285 · Cited by 1,444
Summers, J., & Mason, W. S. (1982) · Cell · doi:10.1016/0092-8674(82)90157-x · Cited by 1,443
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.001 · Cited by 1,347
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
Lai, C.-L., Shouval, D., Lok, A. S., Chang, T.-T., Cheinquer, H., Goodman, Z., DeHertogh, D., Wilber, R., Zink, R. C., Cross, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051287 · Cited by 1,188
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Marcellin, P., Heathcote, E. J., Buti, M., Gane, E., de Man, R. A., Krastev, Z., Germanidis, G., Lee, S. S., Flisiak, R., Kaita, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802878 · Cited by 1,181
Marcellin, P., Lau, G. K. K., Bonino, F., Farci, P., Hadziyannis, S., Jin, R., Lu, Z.-M., Piratvisuth, T., Germanidis, G., Yurdaydin, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040431 · Cited by 1,145
Viral dynamics in hepatitis B virus infection.
Nowak, M. A., Bonhoeffer, S., Hill, A. M., Boehme, R., Thomas, H. C., & McDade, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4398 · Cited by 1,045
Dienstag, J. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801644 · Cited by 961
Werle–Lapostolle, B., Bowden, S., Locarnini, S., Wursthorn, K., Petersen, J., Lau, G., Trepo, C., Marcellin, P., Goodman, Z., & Delaney IV, W. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.018 · Cited by 905
Self-citationLong-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
Hadziyannis, S. J., Tassopoulos, N. C., Heathcote, E. J., Chang, T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S. G., Goodman, Z., Ma, J., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.020 · Cited by 881
Tenney, D. J., Rose, R. E., Baldick, C. J., Pokornowski, K. A., Eggers, B. J., Fang, J., Wichroski, M. J., Xu, D., Yang, J., Wilber, R. B., et al. (2009) · Hepatology · doi:10.1002/hep.22841 · Cited by 804
Clavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B
Lai, C.-L., Gane, E., Liaw, Y.-F., Hsu, C.-W., Thongsawat, S., Wang, Y., Chen, Y., Heathcote, E. J., Rasenack, J., Bzowej, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066422 · Cited by 773
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
Lok, A. S. F., Lai, C.-L., Leung, N., Yao, G.-B., Cui, Z.-Y., Schiff, E. R., Dienstag, J. L., Heathcote, E. J., Little, N. R., Griffiths, D. A., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.033 · Cited by 764
Histological outcome during long-term lamivudine therapy
Dienstag, J. L., Goldin, R. D., Heathcote, E. J., Hann, H. W. L., Woessner, M., Stephenson, S. L., Gardner, S., Gray, D. F., & Schiff, E. R. (2003) · Gastroenterology · doi:10.1053/gast.2003.50013 · Cited by 726
Lai, C., Dienstag, J., Schiff, E., Leung, N. W. Y., Atkins, M., Hunt, C., Brown, N., Woessner, M., Boehme, R., & Condreay, L. (2003) · Clinical Infectious Diseases · doi:10.1086/368083 · Cited by 634
Angus, P., Vaughan, R., Xiong, S., Yang, H., Delaney, W., Gibbs, C., Brosgart, C., Colledge, D., Edwards, R., Ayres, A., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00939-9 · Cited by 564
Self-citationLiaw, Y., Gane, E., Leung, N., Zeuzem, S., Wang, Y., Lai, C. L., Heathcote, E. J., Manns, M., Bzowej, N., Niu, J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.026 · Cited by 562
Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids
Deres, K., Schröder, C. H., Paessens, A., Goldmann, S., Hacker, H. J., Weber, O., Krämer, T., Niewöhner, U., Pleiss, U., Stoltefuss, J., et al. (2003) · Science · doi:10.1126/science.1077215 · Cited by 508
Pollicino, T., Belloni, L., Raffa, G., Pediconi, N., Squadrito, G., Raimondo, G., & Levrero, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.001 · Cited by 472
Lok, A. S., Zoulim, F., Locarnini, S., Bartholomeusz, A., Ghany, M. G., Pawlotsky, J.-M., Liaw, Y.-F., Mizokami, M., & Kuiken, C. (2007) · Hepatology · doi:10.1002/hep.21698 · Cited by 447
Self-citationWursthorn, K., Lutgehetmann, M., Dandri, M., Volz, T., Buggisch, P., Zollner, B., Longerich, T., Schirmacher, P., Metzler, F., Zankel, M., et al. (2006) · Hepatology · doi:10.1002/hep.21282 · Cited by 438
Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., Das, A., Lopes, A. R., Borrow, P., Williams, K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061287 · Cited by 421
Petersen, J., Dandri, M., Mier, W., Lütgehetmann, M., Volz, T., von Weizsäcker, F., Haberkorn, U., Fischer, L., Pollok, J.-M., Erbes, B., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1389 · Cited by 397
Yuen, M.-F., Sablon, E., Hui, C.-K., Yuan, H.-J., Decraemer, H., & Lai, C.-L. (2001) · Hepatology · doi:10.1053/jhep.2001.27563 · Cited by 386
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region
Stuyver, L. (2001) · Hepatology · doi:10.1053/jhep.2001.22166 · Cited by 382
Gripon, P., Cannie, I., & Urban, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1613-1622.2005 · Cited by 347
Lampertico, P., Viganò, M., Manenti, E., Iavarone, M., Sablon, E., & Colombo, M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.079 · Cited by 310
Marcellin, P., Chang, T.-T., Lim, S. G. L., Sievert, W., Tong, M., Arterburn, S., Borroto-Esoda, K., Frederick, D., & Rousseau, F. (2008) · Hepatology · doi:10.1002/hep.22414 · Cited by 306
Sheldon, J., Camino, N., Rodés, B., Bartholomeusz, A., Kuiper, M., Tacke, F., Núñez, M., Mauss, S., Lutz, T., Klausen, G., et al. (2005) · Antiviral Therapy · doi:10.1177/135965350501000612 · Cited by 285
Self-citationMoraleda, G., Saputelli, J., Aldrich, C. E., Averett, D., Condreay, L., & Mason, W. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9392-9399.1997 · Cited by 263
Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus
Delaney, W. E., Ray, A. S., Yang, H., Qi, X., Xiong, S., Zhu, Y., & Miller, M. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00138-06 · Cited by 259
Keeffe, E. B., Zeuzem, S., Koff, R. S., Dieterich, D. T., Esteban–Mur, R., Gane, E. J., Jacobson, I. M., Lim, S. G., Naoumov, N., Marcellin, P., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.004 · Cited by 257
Self-citationFunctional skewing of the global CD8 T cell population in chronic hepatitis B virus infection
Das, A., Hoare, M., Davies, N., Lopes, A. R., Dunn, C., Kennedy, P. T. F., Alexander, G., Finney, H., Lawson, A., Plunkett, F. J., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072076 · Cited by 256
Naturally Occurring Variants of Hepatitis B Virus
Günther, S., Fischer, L., Pult, I., Sterneck, M., & Will, H. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60298-5 · Cited by 255
Evolution of multi-drug resistant hepatitis B virus during sequential therapy
Yim, H. J., Hussain, M., Liu, Y., Wong, S. N., Fung, S. K., & Lok, A. S. F. (2006) · Hepatology · doi:10.1002/hep.21290 · Cited by 253
Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed
Lewin, S. R., Ribeiro, R. M., Walters, T., Lau, G. K., Bowden, S., Locarnini, S., & Perelson, A. S. (2001) · Hepatology · doi:10.1053/jhep.2001.28509 · Cited by 245
Self-citationNew insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA
Zoulim, F. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.015 · Cited by 244
Self-citationManagement of Antiviral Resistance in Patients with Chronic Hepatitis B
Locarnini, S., Hatzakis, A., Heathcote, J., Keeffe, E. B., Liang, T. J., Mutimer, D., Pawlotsky, J.-M., & Zoulim, F. (2004) · Antiviral Therapy · doi:10.1177/135965350400900522 · Cited by 237
Self-citationPawlotsky, J., Dusheiko, G., Hatzakis, A., Lau, D., Lau, G., Liang, T. J., Locarnini, S., Martin, P., Richman, D. D., & Zoulim, F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.036 · Cited by 230
Self-citationSung, J. J. Y., Wong, M.-L., Bowden, S., Liew, C.-T., Hui, A. Y., Wong, V. W. S., Leung, N. W. Y., Locarnini, S., & Chan, H. L. Y. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.009 · Cited by 218
Bim-mediated deletion of antigen-specific CD8+ T cells in patients unable to control HBV infection
Lopes, A. R., Kellam, P., Das, A., Dunn, C., Kwan, A., Turner, J., Peppa, D., Gilson, R. J., Gehring, A., Bertoletti, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33402 · Cited by 218
Margeridon‐Thermet, S., Shulman, N. S., Ahmed, A., Shahriar, R., Liu, T., Wang, C., Holmes, S. P., Babrzadeh, F., Gharizadeh, B., Hanczaruk, B., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597808 · Cited by 206
Chan, H. L. Y., Heathcote, E. J., Marcellin, P., Lai, C.-L., Cho, M., Moon, Y. M., Chao, Y.-C., Myers, R. P., Minuk, G. Y., Jeffers, L., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-11-200712040-00183 · Cited by 192
Drug Targets and Molecular Mechanisms of Drug Resistance in Chronic Hepatitis B
Ghany, M., & Liang, T. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.039 · Cited by 172
Hepatitis B: Reflections on the current approach to antiviral therapy
Zoulim, F., & Perrillo, R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.011 · Cited by 167
Self-citationWeber, O., Schlemmer, K.-H., Hartmann, E., Hagelschuer, I., Paessens, A., Graef, E., Deres, K., Goldmann, S., Niewoehner, U., Stoltefuss, J., et al. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00216-9 · Cited by 163
ZOULIM, F. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.07.003 · Cited by 163
Self-citationDelaney, W. E., Edwards, R., Colledge, D., Shaw, T., Furman, P., Painter, G., & Locarnini, S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3057-3060.2002 · Cited by 158
Self-citationSolmone, M., Vincenti, D., Prosperi, M. C. F., Bruselles, A., Ippolito, G., & Capobianchi, M. R. (2009) · Journal of Virology · doi:10.1128/jvi.02011-08 · Cited by 158
Lamivudine Therapy of WHV-Infected Woodchucks
Mason, W. S., Cullen, J. M., Moraleda, G., Saputelli, J. R., Aldrich, C. E., Miller, D. S., Tennant, B. C., Frick, L., Averett, D. R., Condreay, L. D., et al. (1998) · Virology · doi:10.1006/viro.1998.9150 · Cited by 155
Sung, J. J. �., Lai, J.-Y., Zeuzem, S., Chow, W.-C., Heathcote, E. J., Perrillo, R. P., Brosgart, C. L., Woessner, M. A., Scott, S. A., Gray, D. F., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.026 · Cited by 154
Block, T. M., Lu, X., Mehta, A. S., Blumberg, B. S., Tennant, B. C., Ebling, M., Korba, B. A., Lansky, D. M., Jacob, G. S., & Dwek, R. A. (1998) · Nature Medicine · doi:10.1038/nm0598-610 · Cited by 152
Lok, A. S.-F., Zoulim, F., LOCARNINI, S. A., Mangia, A., Niro, G. A., Decraemer, H., Maertens, G. G., Hulstaert, F., de Vreese, K., & Sablon, E. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3729-3734.2002 · Cited by 152
Self-citationKing, R. W., Ladner, S. K., Miller, T. J., Zaifert, K., Perni, R. B., Conway, S. C., & Otto, M. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3179 · Cited by 144
Control of Hepatitis B Virus Replication by Innate Response of Heparg Cells
Lucifora, J., Durantel, D., Testoni, B., Hantz, O., Levrero, M., & Zoulim, F. (2009) · Hepatology · doi:10.1002/hep.23230 · Cited by 140
Self-citationDelaney, W. E., LOCARNINI, S. A., & Shaw, T. (2001) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020101200101 · Cited by 103
Self-citationDelmas, J., Schorr, O., Jamard, C., Gibbs, C. S., TREPO, C. G., Hantz, O., & Zoulim, F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.425-433.2002 · Cited by 96
Self-citationDynamics of Hepatitis B Virus Resistance to Lamivudine
Pallier, C., Castéra, L., Soulier, A., Hézode, C., Nordmann, P., Dhumeaux, D., & Pawlotsky, J. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.643-653.2006 · Cited by 91
The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B
Richman, D. D. (2000) · Hepatology · doi:10.1053/jhep.2000.18194 · Cited by 85
The concept of hepatitis B virus mutant escape
Pawlotsky, J. (2005) · Journal of Clinical Virology · doi:10.1016/s1386-6532(05)80021-6 · Cited by 84
Köck, J., Baumert, T. F., Delaney, W. E., Blum, H. E., & von Weizsäcker, F. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.009 · Cited by 80
Lazar, C., Durantel, D., Macovei, A., Zitzmann, N., Zoulim, F., Dwek, R. A., & Branza‐Nichita, N. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.04.004 · Cited by 73
Self-citationGuerhier, F. L., Pichoud, C., Guérret, S., Chevallier, M., Jamard, C., Hantz, O., Li, X., Chen, S., King, I., TREPO, C. G., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.111-122.2000 · Cited by 72
Self-citationSeignères, B., Pichoud, C., Ahmed, S. S., Hantz, O., TREPO, C. G., & Zoulim, F. (2000) · The Journal of Infectious Diseases · doi:10.1086/315368 · Cited by 72
Self-citationQuasispecies and the development of new antiviral strategies
Domingo, E. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8012-1_4 · Cited by 70
Lütgehetmann, M., Volz, T., Quaas, A., Zankel, M., Fischer, C., Dandri, M., & Petersen, J. (2008) · Antiviral Therapy · doi:10.1177/135965350801300106 · Cited by 68
Thompson, A. J. V., Colledge, D., Rodgers, S., Wilson, R., Revill, P. A., Desmond, P. V., Mansell, A. S., Visvanathan, K., & LOCARNINI, S. A. (2008) · Antiviral Therapy · doi:10.3851/imp1294 · Cited by 65
Self-citationGlobal control of hepatitis B virus: does treatment-induced antigenic change affect immunization?
Clements, C. J., Coghlan, B., Creati, M., LOCARNINI, S. A., Tedder, R. S., & Torresi, J. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.065722 · Cited by 62
Self-citationSloan, R. D., Ijaz, S., Moore, P. L., Harrison, T. J., Teo, C., & Tedder, R. S. (2008) · Antiviral Therapy · doi:10.1177/135965350801300313 · Cited by 53
Guerhier, F. L., Pichoud, C., Jamard, C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1065-1077.2001 · Cited by 47
Antiviral Therapy of Chronic Hepatitis B: Prevention of Drug Resistance
Fournier, C., & Zoulim, F. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.08.013 · Cited by 43
Self-citationKOCK, J., Baumert, T., BLUM, H., & VONWEIZSACKER, F. (2003) · Hepatology · doi:10.1016/s0270-9139(03)81206-5 · Cited by 25
Cited by
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Jordheim, L. P., Durantel, D., Zoulim, F., & Dumontet, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4010 · Cited by 1,211
Self-citationMechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Nassal, M. (2015) · Gut · doi:10.1136/gutjnl-2015-309809 · Cited by 899
Metadata
- Authors
- Zoulim, F., & Locarnini, S.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 137
- Issue
- 5
- Pages
- 1593-1608.e2
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1978314081
- Cited by
- 706
- References
- 78
- FWCI
- 32.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.